Related Experiment Videos
Control of rabbit myxomatosis in Poland
J Górski1, B Mizak, M Chrobocińska
1National Veterinary Research Institute, Pulawy, Poland.
Revue Scientifique Et Technique (International Office of Epizootics)
|September 1, 1994
Abstract:
The authors present an epizootiological analysis of myxomatosis in Poland. The biological, physical and chemical properties of virus strains used for the production and control of 'Myxovac M' vaccine are discussed. The long-term stability, safety and efficacy of the vaccine are demonstrated. Laboratory experiments were confirmed in large-scale field observations.
Insights
This study analyzes myxomatosis epizootiology in Poland and evaluates the
Area of Science:
- Veterinary Virology
- Epizootiology
Background:
- Myxomatosis is a significant rabbit disease.
- Effective vaccines are crucial for disease control.
Purpose of the Study:
- To conduct an epizootiological analysis of myxomatosis in Poland.
- To discuss the properties of virus strains used in the 'Myxovac M' vaccine.
- To demonstrate the vaccine's stability, safety, and efficacy.
Main Methods:
- Epizootiological analysis of myxomatosis.
- Characterization of virus strains for vaccine production.
- Laboratory testing and large-scale field observations of vaccine performance.
Main Results:
- Detailed analysis of myxomatosis spread in Poland.
- Characterization of biological, physical, and chemical properties of vaccine virus strains.
- Demonstrated long-term stability, safety, and efficacy of the 'Myxovac M' vaccine.
Conclusions:
- The 'Myxovac M' vaccine is stable, safe, and effective.
- Laboratory findings were validated by extensive field observations.
- The vaccine represents a viable tool for myxomatosis control in Poland.